Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Inventory (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Change in Inventory for 10 consecutive years, with $15000.0 as the latest value for Q4 2019.

  • On a quarterly basis, Change in Inventory fell 89.29% to $15000.0 in Q4 2019 year-over-year; TTM through Jun 2020 was -$24000.0, a 92.92% increase, with the full-year FY2019 number at -$259000.0, up 45.47% from a year prior.
  • Change in Inventory was $15000.0 for Q4 2019 at Plus Therapeutics, up from -$39000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $740000.0 in Q3 2015 to a low of -$630000.0 in Q2 2015.
  • A 5-year average of -$97300.0 and a median of -$120500.0 in 2015 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: crashed 2420.0% in 2015, then surged 306.0% in 2016.
  • Plus Therapeutics' Change in Inventory stood at -$500000.0 in 2015, then surged by 43.8% to -$281000.0 in 2016, then surged by 173.31% to $206000.0 in 2017, then plummeted by 32.04% to $140000.0 in 2018, then plummeted by 89.29% to $15000.0 in 2019.
  • Per Business Quant, the three most recent readings for PSTV's Change in Inventory are $15000.0 (Q4 2019), -$39000.0 (Q3 2019), and -$219000.0 (Q2 2019).